Oct 2026· Psychoneuroendocrinology· Vol 194, pp.
108044
· 0 citations· 25 references
Medicine
TL;DR
T3 excess in mouse oxytocin neurons is sufficient to cause significant oxytocin deficits, but insufficient per se to cause detectable abnormalities in behavioral profiles, suggesting that the profound behavioral syndrome previously observed in mice with systemic developmental thyrotoxicosis likely involves other brain neural circuits affected by developmental T3 excess.
Abstract
Deficiencies in oxytocin are associated with neurodevelopmental and behavioral disorders, and the oxytocin gene (Oxt) can be regulated by thyroid hormone. We have previously shown that a systemic excess of thyroid hormone during development causes deficits in oxytocin that are associated with major abnormalities in mood-related and social behaviors. To determine whether the disruption in oxytocin physiology is responsible for these aberrant behaviors we targeted thyroid hormone excess to oxytocin neurons using a mouse model of conditional deficiency of the type 3 deiodinase (DIO3), the neuronal enzyme responsible for the clearance of thyroid hormones and the modulation of thyroid hormone action. We observed that mice of both sexes with T3 excess in oxytocin neurons largely recapitulated the oxytocin deficits of systemic thyrotoxicosis, and exhibited reduced neonatal and adult hypothalamic expression of Oxt mRNA, markedly blunted pituitary Oxt expression and lower serum levels of oxytocin. However, these mice did not show any significant abnormality in physical activity levels, depression- and anxiety-like behaviors, aggression, sociability or maternal behavior. We conclude that T3 excess in mouse oxytocin neurons is sufficient to cause significant oxytocin deficits, but insufficient per se to cause detectable abnormalities in behavioral profiles. Our results suggest that the profound behavioral syndrome previously observed in mice with systemic developmental thyrotoxicosis likely involves other brain neural circuits affected by developmental T3 excess that remain to be identified.
The current understanding of the organizational impacts of hypothyroidism on activity, affective behaviors, cognition, and social behaviors in humans and animal models is discussed, paying special attention to critical periods that may underlie these effects.
In the central nervous system, the neuropeptide oxytocin stimulates neural networks that regulate social behaviors, including social attachment, aggression, and complex social cognition. Perturbations in oxytocin and/or oxytocin receptor expression results in social behavioral deficits and are associated with a number...
Nishita Vattem, Margaret Snyder, Angela Leschinsky et al.· The Neuroscientist· 1 citation
The involvement of oxytocin in social behavior is well established, yet its interaction with neuromodulatory systems, such as serotonin and dopamine, remains incompletely understood. Here, we utilized immunohistochemistry, anatomical tracing, chemogenetic, and ex vivo electrophysiological approaches primarily in male m...
J. Choi, Yoon Kyoung Kim, Yong-Min Sung et al.· eNeuro· 0 citations
Disruptions to maternal behaviors that emerge during the peripartum period have been shown to have lasting physiological and behavioral consequences for offspring. In addition to effects on offspring, disrupted maternal behaviors have been associated with peripartum mood and anxiety disorders. Therefore, it is critical...
Marissa M. Nicodemus, Laiklyn A. M. Luther, Isabella M. Linton et al.· bioRxiv· 0 citations
Due to the ongoing opioid epidemic, there has been a rise in the use of medications for opioid use disorder (MOUD) during pregnancy. This paper examines how buprenorphine (BUP), the new golden standard for MOUD, may disrupt maternal care through dysregulation of the oxytocin (OXT) system. OXT is central to parturition,...
Lauren M. Richardson, A. H. Veenema, Susanne Brummelte· Journal of neuroendocrinolog...· 0 citations
The capacity for excess manganese to alter dopaminergic systems resulting in neurobehavioral deficits is clear, yet far less is known the impact of chronic, lower, sub-toxic manganese exposures. Manganese exposure may affect dopamine synthesis and metabolism, and as such impact drug efficacy. These may also occur to a...
A. Tienda, Ashley Maliakal, R. Jonscher et al.· Neurotoxicology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.